Clinical Trial Update: SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study [Phase 3]

View source ↗

Summary

Open-label safety and tolerability rollover extension study for SPD489 in adults with major depressive disorder; terminated, results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SPD489

Snippet

Sponsor: Shire | Conditions: Major Depressive Disorder | Phase 3 | Status: TERMINATED | Results posted: 2015-02-23